Treatment of hypertension in the prevention and management of ischemic heart disease — a scientific statement from the AHA, ACCF, and ASH.
By: Rosendorf C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Gersh BJ, Gore JH, Levy D, Long JB, O’Gara PT, Oparil S, White WB.
Read on Pubmed
A clinician’s guide to the updated ABCs of cardiovascular disease prevention.
By: Kohli P, Whelton SP, Hsu S, Yancy CW, Stone NJ, Chrispin J, Gilotra NA, Houston B, Ashen MD, Martin SS, Joshi PH, McEvoy JW, Gluckman TJ, Michos ED, Blaha MJ, Blumenthal RS.
To facilitate the guideline-based implementation of treatment recommendations in the ambulatory setting and to encourage participation in the multiple preventive health efforts that exist, we have organized several recent guideline updates into a simple ABCDEF approach. We would remind clinicians that evidence-based medicine is meant to inform recommendations but that synthesis of patient-specific data and use of appropriate clinical judgment in each individual situation is ultimately preferred.
- Journal:
Journal of the American Heart Association
- Year: 2014
- Topics:
Antiplatelet Therapy,
ASCVD (Atherosclerotic Cardiovascular Disease),
Blood Pressure,
Cholesterol / Lipids / Statins,
Cigarette Smoking,
Diabetes & Metabolic Syndrome,
Diet & Weight,
Exercise and Physical Fitness,
Quality of Care
- Read more articles by:
Roger S. Blumenthal, MD,
Michael Blaha, MD, MPH,
Erin Michos, MD, MHS,
Marie (Dominique) Ashen, CRNP, PhD,
Seth Martin, MD, MHS,
J. Bill McEvoy, MB BCh, MHS
Read on Pubmed
Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?
By: Kim C, Golden SH, Kong S, Nan B, Mather KJ, Barrett-Connor, Diabetes Prevention Program Research Group.
Among overweight women with dysglycemia, the magnitude of blood pressure reductions after intensive lifestyle change is unrelated to postmenopausal estrogen use.
Read on Pubmed
Does hormone therapy affect blood pressure in the Diabetes Prevention Program?
By: Kim C, Golden SH, Kong S, Nan B, Mather K, Barrett-Connor E; for the Diabetes Prevention Program Research Group.
This study aims to examine whether blood pressure reductions differ by estrogen use among overweight glucose-intolerant women. Among overweight women with dysglycemia, the magnitude of blood pressure reductions after ILS is unrelated to postmenopausal estrogen use.
Read on Pubmed
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk.
By: Abd TT, Misra S, Ojeifo O, Martin SS, Blumenthal RS, Foody J, Wong ND.
The 2013 lifestyle guidelines provide guidance in three narrowly focused areas: 1) the effect of dietary patterns and macronutrient composition on CVD risk factors; 2) the effect of sodium and potassium on CVD risk factors; and 3) the effect of physical activity on blood pressure and lipids.
- Year: 2014
- Topics:
ASCVD (Atherosclerotic Cardiovascular Disease),
Blood Pressure,
Cholesterol / Lipids / Statins,
Cigarette Smoking,
Diet & Weight,
Exercise and Physical Fitness,
Nutrition, Vitamins, Supplements,
Cardiovascular Risk Assessment
- Read more articles by:
Roger S. Blumenthal, MD,
Seth Martin, MD, MHS
Read on Pubmed
Focused update on the 2013-2014 cardiovascular disease prevention guidelines.
By: Abd TT, Misra S, Ojeifo O, Martin SS, Blumenthal RS, Foody J, Wong ND.
Polypill therapy, subclinical atherosclerosis, and cardiovascular events — implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis).
By: Bittencourt MS, Blaha MJ, Blankstein R, Budoff M, Vargas JD, Blumenthal RS, Agatston AS, Nasir K.
The authors conclude that avoidance of polypill therapy in individuals with subclinical atherosclerosis could allow for a more selective use of the treatment and, as a result, avoidance of treatment in those who are unlikely to benefit.
- Journal:
Journal of the American College of Cardiology
- Year: 2014
- Topics:
ASCVD (Atherosclerotic Cardiovascular Disease),
Antiplatelet Therapy,
Blood Pressure,
Cholesterol / Lipids / Statins,
Quality of Care,
Cardiovascular Risk Assessment
- Read more articles by:
Roger S. Blumenthal, MD,
Michael Blaha, MD, MPH,
Khurram Nasir, MD, MPH
Read on Pubmed
Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk.
By: Seif F, Patel SR, Walia HK, Rueschman M, Bhatt DL, Blumenthal RS, Quan SF, Gottlieb DJ, Lewis EF, Patil SP, Punjabi NM, Babineau DC, Redline S, Mehra R.
Progressive blood pressure burden is associated with increased obstructive sleep apnea severity, even in patients managed by cardiology specialty care.
Read on Pubmed
Response to importance of pressure pulse amplification in the association of resting heart rate and arterial stiffness.
By: Whelton SP, Blaha MJ.
Read on Pubmed
Association of resting heart rate with carotid and aortic arterial stiffness: Multi-Ethnic Study of Atherosclerosis.
By: Whelton SP, Blankstein R, Al-Mallah MH, Lima JA, Bluemke DA, Hundley WG, Polak JF, Blumenthal RS, Nasir K, Blaha MJ.
Results from this study suggest that a higher resting heart rate is associated with an increased arterial stiffness independent of atrioventricular nodal blocker use and physical activity level, with a stronger association for a peripheral (carotid) compared with a central (aorta) artery.
Read on Pubmed
